newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics Announces Publication of Tomivosertib Preclinical Data in Cell Reports

SAN DIEGO, July 16, 2021 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation inhibitors ("STRIs") for the treatment of cancer, announced today the publication of data highlighting the role of